Stephen Harding
Overview
Explore the profile of Stephen Harding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee D, El-Khoury H, Tramontano A, Alberge J, Perry J, Davis M, et al.
Blood Adv
. 2024 Jan;
8(7):1737-1746.
PMID: 38212245
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant condition of multiple myeloma with few known risk factors. The emergence of mass spectrometry (MS) for the detection of MGUS has...
12.
Rognvaldsson S, Thorsteinsdottir S, Syriopoulou E, Sverrisdottir I, Turesson I, Eythorsson E, et al.
Haematologica
. 2024 Jan;
109(7):2250-2255.
PMID: 38205512
There is some evidence that a prior cancer is a risk factor for the development of multiple myeloma (MM). If this is true, prior cancer should be associated with a...
13.
Bomsztyk J, Ravichandran S, Giles H, Wright N, Berlanga O, Khwaja J, et al.
Blood
. 2024 Jan;
143(13):1259-1268.
PMID: 38194690
Amyloidogenic serum free light chains (sFLCs) drive disease progression in AL amyloidosis. Matrix-assisted laser desorption/ionization time of flight mass spectrometry-based FLC assay (FLC-MS) has greater sensitivity than conventional sFLC assays...
14.
Perez-Escurza O, Flores-Montero J, Oskarsson J, Sanoja-Flores L, Del Pozo J, Lecrevisse Q, et al.
Blood Cancer J
. 2023 Dec;
13(1):182.
PMID: 38072838
Monoclonal gammopathy of undetermined significance (MGUS) is the earliest discernible stage of multiple myeloma (MM) and Waldenström's macroglobulinemia (WM). Early diagnosis of MG may be compromised by the low-level infiltration,...
15.
Oskarsson J, Rognvaldsson S, Thorsteinsdottir S, Aspelund T, Gunnarsson S, Hakonardottir G, et al.
Blood Cancer J
. 2023 Dec;
13(1):177.
PMID: 38040702
Hemodilution of bone marrow (BM) aspirates is a limitation of multiparameter flow cytometry (MFC) in plasma cell disorders. There is a need for a validated approach for assessing sample quality...
16.
Sigurbergsdottir A, Rognvaldsson S, Thorsteinsdottir S, Sverrisdottir I, Sigurdardottir G, Vidarsson B, et al.
Haematologica
. 2023 Jul;
108(12):3392-3398.
PMID: 37439374
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor condition that precedes multiple myeloma and related disorders but has also been associated with other medical conditions. Since systematic screening...
17.
Thorsteinsdottir S, Gislason G, Aspelund T, Rognvaldsson S, Oskarsson J, Sigurdardottir G, et al.
Nat Med
. 2023 Mar;
29(12):3269.
PMID: 36941333
No abstract available.
18.
Rognvaldsson S, Love T, Thorsteinsdottir S, Reed E, Oskarsson J, Petursdottir I, et al.
Blood Cancer J
. 2023 Mar;
13(1):39.
PMID: 36935437
No abstract available.
19.
Thorsteinsdottir S, Gislason G, Aspelund T, Rognvaldsson S, Oskarsson J, Sigurdardottir G, et al.
Nat Med
. 2023 Feb;
29(2):467-472.
PMID: 36747117
Smoldering multiple myeloma (SMM) is an asymptomatic precursor to multiple myeloma. Here we define the epidemiological characteristics of SMM in the general population in Iceland. The iStopMM study (ClinicalTrials.gov ID:...
20.
Long T, Indridason O, Palsson R, Rognvaldsson S, Love T, Thorsteinsdottir S, et al.
Blood Cancer J
. 2022 Sep;
12(9):133.
PMID: 36100605
Serum free light chain (FLC) concentration is greatly affected by kidney function. Using a large prospective population-based cohort, we aimed to establish a reference interval for FLCs in persons with...